newsfilter
← Latest News
GlobeNewswire·

Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business Highlights

ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales were $28.2 million in Q2 2021, reflecting growth of 15% over the previous quarter Net loss in Q2 2021 decreased by $10.4 million (32%), as compared to Q2 2020, duri